7,795
Views
55
CrossRef citations to date
0
Altmetric
Review

Orbital atherectomy for the treatment of severely calcified coronary lesions: evidence, technique, and best practices

ORCID Icon, , , , , , , , , , & ORCID Icon show all
Pages 867-879 | Received 08 Sep 2017, Accepted 22 Sep 2017, Published online: 04 Oct 2017

References

  • Lee MS, Shah N. The impact and pathophysiologic consequences of coronary artery calcium deposition in percutaneous coronary interventions. J Invasive Cardiol. 2016;28:160–167.
  • Mintz GS. Intravascular imaging of coronary calcification and its clinical implications. JACC Cardiovasc Imaging. 2015;8:461–471.
  • Polonsky TS, McClelland RL, Jorgensen NW, et al. Coronary artery calcium score and risk classification for coronary heart disease prediction. JAMA. 2010;303:1610–1616.
  • Yano Y, O’Donnell CJ, Kuller L, et al. Association of coronary artery calcium score vs age with cardiovascular risk in older adults: an analysis of pooled population-based studies. JAMA Cardiol. 2017 Jul 26:9. DOI: 10.1001/jamacardio.2017.2498
  • Genereux P, Madhavan MV, Mintz GS, et al. Ischemic outcomes after coronary intervention of calcified vessels in acute coronary syndromes: pooled analysis from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) and ACUITY (acute catheterization and urgent intervention triage strategy) trials. J Am Coll Cardiol. 2014;63:1845–1854.
  • Chambers JW, Diage T. Evaluation of the Diamondback 360 coronary orbital atherectomy system for treating de novo, severely calcified lesions. Expert Rev Med Devices. 2014;11:457–466.
  • Leopold JA. Vascular calcification: mechanisms of vascular smooth muscle cell calcification. Trends Cardiovasc Med. 2015;25:267–274.
  • Bourantas CV, Zhang Y-J, Garg S, et al. Prognostic implications of coronary calcification in patients with obstructive coronary artery disease treated by percutaneous coronary intervention: a patient-level pooled analysis of 7 contemporary stent trials. Heart. 2014;100:1158–1164.
  • Mintz GS, Popma JJ, Pichard AD, et al. Patterns of calcification in coronary artery disease. A statistical analysis of intravascular ultrasound and coronary angiography in 1155 lesions. Circulation. 1995;91:1959–1965.
  • Mozaffarian D, Benjamin EJ, Go AS, et al. Heart disease and stroke statistics–2015 update: a report from the American Heart Association. Circulation. 2015;131:e29–e322.
  • Madhavan MV, Tarigopula M, Mintz GS, et al. Coronary artery calcification: pathogenesis and prognostic implications. J Am Coll Cardiol. 2014;63:1703–1714.
  • Otsuka F, Sakakura K, Yahagi K, et al. Has our understanding of calcification in human coronary atherosclerosis progressed? Arter Thromb Vasc Biol. 2014;34:724–736.
  • Mosseri M, Satler LF, Pichard AD, et al. Impact of vessel calcification on outcomes after coronary stenting. Cardiovasc Revasc Med. 2005;6:147–153.
  • Colombo A, Stankovic G. Coronary perforations: old screenplay, new actors! J Invasive Cardiol. 2004;16:302–303.
  • Onuma Y, Tanimoto S, Ruygrok P, et al. Efficacy of everolimus eluting stent implantation in patients with calcified coronary culprit lesions: two-year angiographic and three-year clinical results from the SPIRIT II study. Catheter Cardiovasc Interv. 2010;76:634–642.
  • Schlüter M, Cosgrave J, Tübler T, et al. Rotational atherectomy to enable sorolimus-eluting stent implantation in calcified, nondilatable de novo coronary artery lesions. Vasc Manag. 2007;4:63–69.
  • Cavusoglu E, Kini AS, Marmur JD, et al. Current status of rotational atherectomy. Catheter Cardiovasc Interv. 2004;62:485–498.
  • Moussa I, Di Mario C, Moses J, et al. Coronary stenting after rotational atherectomy in calcified and complex lesions. Angiographic and clinical follow-up results. Circulation. 1997;96:128–136.
  • Benezet J, Diaz de la Llera LS, Cubero JM, et al. Drug-eluting stents following rotational atherectomy for heavily calcified coronary lesions: long-term clinical outcomes. J Invasive Cardiol. 2011;23:28–32.
  • Nakano M, Otsuka F, Yahagi K, et al. Human autopsy study of drug-eluting stents restenosis: histomorphological predictors and neointimal characteristics. Eur Heart J. 2013;34:3304–3313.
  • Nishida K, Kimura T, Kawai K, et al. Comparison of outcomes using the sirolimus-eluting stent in calcified versus non-calcified native coronary lesions in patients on- versus not on-chronic hemodialysis (from the j-Cypher registry). Am J Cardiol. 2013;112:647–655.
  • Moussa I, Ellis SG, Jones M, et al. Impact of coronary culprit lesion calcium in patients undergoing paclitaxel-eluting stent implantation (a TAXUS-IV sub study). Am J Cardiol. 2005;96:1242–1247.
  • Clavijo LC, Steinberg DH, Torguson R, et al. Sirolimus-eluting stents and calcified coronary lesions: clinical outcomes of patients treated with and without rotational atherectomy. Catheter Cardiovasc Interv. 2006;68:873–878.
  • Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol. 2011;58:e44–e122.
  • Fitzgerald PJ, Ports TA, Yock PG. Contribution of localized calcium deposits to dissection after angioplasty. An observational study using intravascular ultrasound. Circulation. 1992;86:64–70.
  • Gilutz H, Weinstein JM, Ilia R. Repeated balloon rupture during coronary stenting due to a calcified lesion: an intravascular ultrasound study. Catheter Cardiovasc Interv. 2000;50:212–214.
  • Kahn JK, Hartzler GO. Balloon rupture due to lesion morphology during coronary angioplasty. Cathet Cardiovasc Diagn. 1990;21:89–91.
  • Bentzon JF, Otsuka F, Virmani R, et al. Mechanisms of plaque formation and rupture. Circ Res. 2014;114:1852–1866.
  • Serruys PW, van Hout B, Bonnier H, et al. Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II). Lancet. 1998;352:673–681.
  • Pinto DS, Stone GW, Ellis SG, et al. Impact of routine angiographic follow-up on the clinical benefits of paclitaxel-eluting stents: results from the TAXUS-IV trial. J Am Coll Cardiol. 2006;48:32–36.
  • Brown DL, George CJ, Steenkiste AR, et al. High-speed rotational atherectomy of human coronary stenoses: acute and one-year outcomes from the new approaches to coronary intervention (NACI) registry. Am J Cardiol. 1997;80:60K–67K.
  • Garcia de Lara J, Pinar E, Ramon Gimeno J, et al. Percutaneous coronary intervention in heavily calcified lesions using rotational atherectomy and paclitaxel-eluting stents: outcomes at one year. Rev Esp Cardiol. 2010;63:107–110.
  • Khattab AA, Otto A, Hochadel M, et al. Drug-eluting stents versus bare metal stents following rotational atherectomy for heavily calcified coronary lesions: late angiographic and clinical follow-up results. J Interv Cardiol. 2007;20:100–106.
  • Arora S, Panaich SS, Patel N, et al. Coronary atherectomy in the United States (from a nationwide inpatient sample). Am J Cardiol. 2016;117:555–562.
  • Chambers JW, Behrens AN, Martinsen BJ. Atherectomy devices for the treatment of calcified coronary lesions. Interv Cardiol Clin. 2016;5:143–151.
  • Chambers J, Martinsen B Orbital atherectomy in the coronary arteries. Textb. Atherectomy. 1st ed. HMP Communications, LLC; 2016. p. 217–240.
  • Sotomi Y, Shlofmitz R, Colombo A, et al. Patient selection and procedural considerations for coronary orbital atherectomy system. Interv Cardiol Rev. 2016;11:33–38.
  • Parikh K, Chandra P, Choksi N, et al. Safety and feasibility of orbital atherectomy for the treatment of calcified coronary lesions: the ORBIT I trial. Catheter Cardiovasc Interv. 2013;81:1134–1139.
  • Kini AS, Vengrenyuk Y, Pena J, et al. Optical coherence tomography assessment of the mechanistic effects of rotational and orbital atherectomy in severely calcified coronary lesions. Catheter Cardiovasc Interv. 2015;86:1024–1032.
  • Ueda H, Kini A. Optical coherence tomography-guided bioresorbable vascular scaffold implantation with orbital atherectomy for calcified chronic total occlusion. Cath Lab Dig. 2016;24. Available from: http://www.cathlabdigest.com/article/Optical-Coherence-Tomography-Guided-Bioresorbable-Vascular-Scaffold-Implantation-Orbital
  • Sotomi Y, Cavalcante R, Shlofmitz RA, et al. Quantification by optical coherence tomography imaging of the ablation volume obtained with the orbital atherectomy system in calcified coronary lesions. EuroIntervention. 2016;12:1126–1134.
  • Galougahi KK, Shlofmitz RA, Ben-Yehuda O, et al. Guiding light: insights into atherectomy by optical coherence tomography. JACC Cardiovasc Interv. 2016;9:2362–2363.
  • Zheng Y, Belmont B, Shih AJ. Experimental investigation of the abrasive crown dynamics in orbital atherectomy. Med Eng Phys. 2016;38:639–647.
  • Sotomi Y, Shammas NW, Suwannasom P, et al. Impact of the orbital atherectomy system on a peripheral calcified lesion: quantitative analysis by intravascular echogenicity. JACC Cardiovasc Interv. 2015;8:e205–e206.
  • Galougahi KK, Bhatti N, Shlofmitz R, et al. TCT-236 effects of orbital versus rotational atherectomy facilitated PCI on the coronary microcirculation. J Am Coll Cardiol. 2016;68:B96.
  • Bhatt P, Parikh P, Patel A, et al. Orbital atherectomy system in treating calcified coronary lesions: 3-Year follow-up in first human use study (ORBIT I trial). Cardiovasc Revasc Med. 2014;15:204–208.
  • Bhatt P, Parikh P, Patel A, et al. Long-term safety and performance of the orbital atherectomy system for treating calcified coronary artery lesions: 5-year follow-up in the ORBIT I trial. Cardiovasc Revasc Med. 2015;16:213–216.
  • Chambers JW, Feldman RL, Himmelstein SI, et al. Pivotal trial to evaluate the safety and efficacy of the orbital atherectomy system in treating de novo, severely calcified coronary lesions (ORBIT II). JACC Cardiovasc Interv. 2014;7:510–518.
  • Généreux P, Lee AC, Kim CY, et al. Orbital atherectomy for treating de novo severely calcified coronary narrowing (1-year results from the pivotal ORBIT II trial). Am J Cardiol. 2015;115:1685–1690.
  • Généreux P, Bettinger N, Redfors B, et al. Two-year outcomes after treatment of severely calcified coronary lesions with the orbital atherectomy system and the impact of stent types: insight from the ORBIT II trial. Catheter Cardiovasc Interv. 2016;88:369–377.
  • Lee M, Généreux P, Shlofmitz R, et al. Orbital atherectomy for treating de novo, severely calcified coronary lesions: 3-year results of the pivotal ORBIT II trial. Cardiovasc Revasc Med. 2017;18:261–264.
  • Lee MS, Shlofmitz E, Kaplan B, et al. Real-world multicenter registry of patients with severe coronary artery calcification undergoing orbital atherectomy. J Interv Cardiol. 2016;29:357–362.
  • Kim CY, Lee AC, Wiedenbeck TL, et al. Gender differences in acute and 30-day outcomes after orbital atherectomy treatment of de novo, severely calcified coronary lesions. Catheter Cardiovasc Interv. 2016;87:671–677.
  • Lee MS, Shlofmitz E, Shlofmitz R, et al. Outcomes after orbital atherectomy of severely calcified left main lesions: analysis of the ORBIT II study. J Invasive Cardiol. 2016;28:364–369.
  • Lee MS, Martinsen BJ, Shlofmitz R, et al. Orbital atherectomy treatment of severely calcified coronary lesions in patients with impaired left ventricular ejection fraction: one-year outcomes from the ORBIT II study. EuroIntervention. 2017;13:329–337.
  • Lee MS, Lee AC, Shlofmitz RA, et al. ORBIT II sub-analysis: impact of impaired renal function following treatment of severely calcified coronary lesions with the orbital atherectomy system. Catheter Cardiovasc Interv. 2017;89:841–848.
  • Lee MS, Shlofmitz E, Lluri G, et al. Outcomes in elderly patients with severely calcified coronary lesions undergoing orbital atherectomy. J Interv Cardiol. 2017;30:134–138.
  • Shlofmitz E, Meraj P, Jauhar R, et al. Safety of orbital atherectomy in patients with left ventricular systolic dysfunction. J Interv Cardiol. 2017 Jul 19:6. DOI: 10.1111/joic.12405
  • Lee MS, Shlofmitz E, Lluri G, et al. Outcomes of patients with myocardial infarction who underwent orbital atherectomy for severely calcified lesions. Cardiovasc Revasc Med. 2017 May 7. DOI:10.1016/j.carrev.2017.05.005.
  • Lee MS, Nguyen H, Shlofmitz R. Incidence of bradycardia and outcomes of patients who underwent orbital atherectomy without a temporary pacemaker. J Invasive Cardiol. 2017;29:59–62.
  • Lee MS, Shlofmitz E, Lluri G, et al. Impact of impaired renal function in patients with severely calcified coronary lesions treated with orbital atherectomy. J Invasive Cardiol. 2017;29:203–206.
  • Lee MS, Shlofmitz E, Mansourian P, et al. Gender-based differences in outcomes after orbital atherectomy for the treatment of de novo severely calcified coronary lesions. J Invasive Cardiol. 2016;28:440–443.
  • Lee MS, Shlofmitz E, Nguyen H, et al. Outcomes in diabetic patients undergoing orbital atherectomy system. J Interv Cardiol. 2016;29:491–495.
  • Lee MS, Shlofmitz E, Kaplan B, et al. Percutaneous coronary intervention in severely calcified unprotected left main coronary artery disease: initial experience with orbital atherectomy. J Invasive Cardiol. 2016;28:147–150.
  • Ruisi M, Zachariah J, Ratcliffe J, et al. Safety and feasibility of the coronary orbital atherectomy system via the transradial approach. J Invasive Cardiol. 2015;27:E252–E255.
  • Shlofmitz E, Martinsen B, Lee M, et al. Utilizing intravascular ultrasound imaging prior to treatment of severely calcified coronary lesions with orbital atherectomy: an ORBIT II sub-analysis. J Interv Cardiol. 2017 Aug 7:7. DOI: 10.1111/joic.12423
  • Lee MS, Martinsen BJ, Lee AC, et al. Impact of diabetes mellitus on procedural and one year clinical outcomes following treatment of severely calcified coronary lesions with the orbital atherectomy system: a subanalysis of the ORBIT II study. Catheter Cardiovasc Interv. 2017 Jul 22:8. DOI: 10.1002/ccd.27208
  • Chambers J, Généreux P, Lee A, et al. The potential cost-effectiveness of the Diamondback 360® coronary orbital atherectomy system for treating de novo, severely calcified coronary lesions: an economic modeling approach. Ther Adv Cardiovasc Dis. 2016;10:74–85.
  • Abdel-Wahab M, Richardt G, Joachim Büttner H, et al. High-speed rotational atherectomy before paclitaxel-eluting stent implantation in complex calcified coronary lesions: the randomized ROTAXUS (rotational atherectomy prior to taxus stent treatment for complex native coronary artery disease) trial. JACC Cardiovasc Interv. 2013;6:10–19.
  • de Waha S, Allali A, Büttner H-J, et al. Rotational atherectomy before paclitaxel-eluting stent implantation in complex calcified coronary lesions: two-year clinical outcome of the randomized ROTAXUS trial. Catheter Cardiovasc Interv. 2016;87:691–700.
  • Généreux P, Redfors B, Witzenbichler B, et al. Two-year outcomes after percutaneous coronary intervention of calcified lesions with drug-eluting stents. Int J Cardiol. 2017;231:61–67.
  • Redfors B, Maehara A, Witzenbichler B, et al. Outcomes after successful percutaneous coronary intervention of calcified lesions using rotational atherectomy, cutting balloon angioplasty, or balloon-only angioplasty before drug-eluting stent implantation. J Invasive Cardiol. 2017 Jun 15: 11. pii: JIC2017615-2
  • Allali A, Abdel-Wahab M, Sulimov DS, et al. Comparison of bailout and planned rotational atherectomy for heavily calcified coronary lesions: a single-center experience. J Interv Cardiol. 2017;30:124–133.
  • Buccheri D, Piraino D, Andolina G, et al. Understanding and managing in-stent restenosis: a review of clinical data, from pathogenesis to treatment. J Thorac Dis. 2016;8:E1150–E1162.
  • Witzenbichler B, Maehara A, Weisz G, et al. Relationship between intravascular ultrasound guidance and clinical outcomes after drug-eluting stents: the assessment of dual antiplatelet therapy with drug-eluting stents (ADAPT-DES) study. Circulation. 2014;129:463–470.
  • Lee MS, Shlofmitz E, Kaplan B, et al. Outcomes of patients with severely calcified aorto-ostial coronary lesions who underwent orbital atherectomy. J Interv Cardiol. 2017 Sep 4:6. DOI: 10.1111/joic.12432
  • Al Suwaidi J, Berger PB, Rihal CS, et al. Immediate and long-term outcome of intracoronary stent implantation for true bifurcation lesions. J Am Coll Cardiol. 2000;35:929–936.
  • Iakovou I, Ge L, Colombo A. Contemporary stent treatment of coronary bifurcations. J Am Coll Cardiol. 2005;46:1446–1455.
  • Sharma SK, Sweeny J, Kini AS. Coronary bifurcation lesions: a current update. Cardiol Clin. 2010;28:55–70.
  • Suárez de Lezo J, Medina A, Martín P, et al. Predictors of ostial side branch damage during provisional stenting of coronary bifurcation lesions not involving the side branch origin: an ultrasonographic study. EuroIntervention. 2012;7:1147–1154.
  • Karanasos A, Tu S, van der Heide E, et al. Carina shift as a mechanism for side-branch compromise following main vessel intervention: insights from three-dimensional optical coherence tomography. Cardiovasc Diagn Ther. 2012;2:173–177.
  • Chambers JW, Warner C, Behrens A, et al. Outcomes after atherectomy treatment of severely calcified coronary bifurcation lesions: a single center experience (SCAI-A046). Catheter Cardiovasc Interv. 2017;89:S1–S226.
  • Shlofmitz E, Chambers J, Lee M, et al. Incidence of temporary transvenous pacemaker placement with coronary orbital atherectomy compared to rotational atherectomy. J Am Coll Cardiol. 2016;67:218.
  • Adams GL, Khanna PK, Staniloae CS, et al. Optimal techniques with the Diamondback 360 degrees system achieve effective results for the treatment of peripheral arterial disease. J Cardiovasc Transl Res. 2011;4:220–229.
  • Shlofmitz E, Chambers J, Moses JW, et al. TCT-389 temporary pacemaker placement incidence with the diamondback 360® coronary orbital atherectomy system compared to rotational atherectomy. J Am Coll Cardiol. 2015;66:B157.
  • Kirtane AJ, Doshi D, Leon MB, et al. Treatment of higher-risk patients with an indication for revascularization: evolution within the field of contemporary percutaneous coronary intervention. Circulation. 2016;134:422–431.
  • Heidenreich PA, Trogdon JG, Khavjou OA, et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation. 2011;123:933–944.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.